We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£890.00
It has never been this cheap. We have no record of a lower price.
£890 today · cheaper than every other day in the last 3 months
The 2027-2032 World Outlook for Genital Herpes Treatments
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 88 days · 88 data points
Historical
Generating forecast…
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
Price distribution over 88 days • 1 price levels
Price Analysis
Most common price: £890 (88 days, 100.0%)
Price range: £890 - £890
Price levels: 1 different prices over 88 days
Description
This study covers the world outlook for genital herpes treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of genital herpes treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbott Laboratories, GlaxoSmithKline, Mylan NV, Novartis, and Sun Pharmaceuticals Industries. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2026).
Product Specifications
- Format
- paperback
- ASIN
- B0GMD6NZG5
- Domain
- Amazon UK
- Release Date
- 05 January 2026
- Listed Since
- 08 February 2026
Similar Products You Might Like
99% match
The 2026-2031 World Outlook for Genital Herpes Treatments
£885.00
21 Oct 2026
98% match
The 2027-2032 World Outlook for Herpes Simplex Virus Treatments
£890.00
19 Sep 2026
98% match
The 2026-2031 World Outlook for Herpes Simplex Virus Treatments
£885.00
22 Oct 2026
98% match
The 2023-2028 Outlook for Herpes Simplex Virus Infections in the United States
£520.00
19 Aug 2026
98% match
The 2023-2028 Outlook for Herpes Simplex Virus Infections in India
£515.00
19 Aug 2026
98% match
The 2023-2028 World Outlook for Herpes Simplex Virus Treatments
Price unavailable
98% match
The 2025-2030 World Outlook for Herpes Simplex Virus Treatments
Price unavailable
98% match
The 2023 Report on Herpes Simplex Virus Infections: World Market Segmentation by City
£795.00
21 Aug 2026
98% match
The 2025-2030 World Outlook for Herpes Simplex Virus Infections
Price unavailable
98% match
The 2023-2028 World Outlook for Herpes Simplex Virus Infections
Price unavailable
98% match
The 2023-2028 Outlook for Herpes Marker Testing in the United States
£520.00
22 Aug 2026
98% match
The 2023-2028 Outlook for Herpes Simplex Virus Infections in Japan
£495.00
11 Aug 2026
98% match
The 2023-2028 Outlook for Herpes Marker Testing in India
£515.00
20 Aug 2026
97% match
The 2025-2030 World Outlook for Viral Culture Herpes Marker Testing
Price unavailable
97% match
The 2025-2030 World Outlook for Herpes Marker Testing
Price unavailable
97% match
The 2023-2028 Outlook for Herpes Marker Testing in Japan
£495.00
27 Aug 2026
97% match
The 2023-2028 Outlook for Herpes Marker Testing in China
£495.00
20 Aug 2026
97% match
The 2023-2028 Outlook for Herpes Marker Testing for US Zip Codes
£490.00
23 Aug 2026
97% match
Human Herpesvirus Infection: Biological Features, Transmission, Symptoms, Diagnosis and Treatment
IntechOpen
£118.98
19 Sep 2026
96% match
Human Herpesviruses: 1045 (Advances in Experimental Medicine and Biology, 1045)
Springer
£158.43
20 Aug 2026
96% match
Herpes Simplex Virus: Methods and Protocols: 2060 (Methods in Molecular Biology, 2060)
Humana
£89.28
25 Sep 2026
96% match
Rapp ∗herpesvirus∗
Wiley
Price unavailable
96% match
Pathogenicity of Human Herpesviruses due to Specific Pathogenicity Genes: 3 (Frontiers of Virology, 3)
Springer
£76.42
17 Oct 2026
96% match
IntechOpen Herpesviridae - A Look Into This Virus Family
IntechOpen
£131.45
21 Oct 2026